by | Jul 2, 2024 | Publications
Br J Haematol. 2024 Jul 1. doi: 10.1111/bjh.19623. Online ahead of print. ABSTRACT This Good Practice Paper provides recommendations for the diagnosis and initial management of transplant-eligible high-risk myeloma patients. It describes recent updates to the genetic...
by | Jul 2, 2024 | Publications
Cureus. 2024 Jun 1;16(6):e61504. doi: 10.7759/cureus.61504. eCollection 2024 Jun. ABSTRACT BACKGROUND: Multiple myeloma (MM) immunophenotyping (IPT) and measurable residual disease (MRD) monitoring by flow cytometry is a surrogate for progression-free survival and...
by | Jul 2, 2024 | Publications
Zhonghua Xue Ye Xue Za Zhi. 2024 Apr 14;45(4):345-350. doi: 10.3760/cma.j.cn121090-20231203-00289. ABSTRACT Objective: This study investigated the efficacy and safety of denosumab (DENOS) versus zoledronic acid (ZOL) in the bone disease treatment of newly diagnosed...
by | Jul 2, 2024 | Publications
Zhonghua Xue Ye Xue Za Zhi. 2024 Apr 14;45(4):351-356. doi: 10.3760/cma.j.cn121090-20231124-00274. ABSTRACT Objective: The effect and safety of etoposide combined with G-CSF were compared with those of cyclophosphamide combined with G-CSF in autologous peripheral...
by | Jul 2, 2024 | Publications
Zhonghua Xue Ye Xue Za Zhi. 2024 Apr 14;45(4):378-382. doi: 10.3760/cma.j.issn.0253-2727.2023.01.001. ABSTRACT Objective: The effect of bone marrow soluble B cell maturation antigen (sBCMA) expression on the efficacy and side effects of chimeric antigen receptor (CAR)...
by | Jul 1, 2024 | Publications
J Gene Med. 2024 Jul;26(7):e3712. doi: 10.1002/jgm.3712. ABSTRACT Aggrephagy, a type of autophagy, degrades the aggregation of misfolded protein in cells. However, the role of aggrephagy in multiple myeloma (MM) has not been fully demonstrated. In this study, we first...
